A combination of lycopene and human amniotic epithelial cells can ameliorate cognitive deficits and suppress neuroinflammatory signaling by choroid plexus in Alzheimer's disease rat

Zhiguo Xu,Chao Liu,Rui Wang,Xiren Gao,Chao Hao,Chongbin Liu
DOI: https://doi.org/10.1016/j.jnutbio.2020.108558
IF: 6.117
2021-02-01
The Journal of Nutritional Biochemistry
Abstract:<p>Neuroinflammation characterized by glial activation and release of proinflammatory mediators is considered to be correlated with cognitive deficits in Alzheimer's disease (AD). Previously, some studies have demonstrated that lycopene (LYCO) or human amniotic epithelial cells (HAECs) could attenuate inflammation in AD. Specifically, the choroid plexus (CP), an epithelial layer that forms the blood-cerebrospinal fluid barrier (BCSFB), is able to modulate the cognitive function, through changes in the neuroinflammatory response and in brain immune surveillance. However, it is unclear if LYCO can interact with HAECs to improve neuroinflammation at the CP. Thus, this study chose the region of interest, considered the feasibility of using a combination of LYCO and HAECs, as a therapeutic agent for immunomodulatory effects at the CP in an acutely induced AD rat model. Results showed that oral administration of LYCO, HAECs transplantation and their combination significantly improved cognitive deficits in water maze test, decreased the level of proinflammatory mediators (TNF-α and IL-1β), increased the level of anti-inflammatory mediators (IL-10 and TGF-β1) in the cerebro-spinal fluid (CSF) and hippocampal tissue. Interestingly, LYCO administration, HAECs transplantation and their combination reversed the Aβ<sub>1–42</sub> induced up-regulation of Toll like receptor 4 (TLR4) and nuclear factor- κB p65 (NF-κB p65) mRNA and protein expressions at the CP. This study provided the novel experimental evidence for the influence of co-treatment with LYCO and HAECs on immunomodulatory capabilities of CP. It could also warrant therapeutic window for the pathophysiology of AD and the associated underlying mechanisms at the CP.</p>
biochemistry & molecular biology,nutrition & dietetics
What problem does this paper attempt to address?